R&D expense · 2013–2025
Novocure R&D expense
$225M+7.1% · FY2025
Novocure (NVCR) reported $225M in R&D expense for fiscal 2025, +7.1% year on year.
| Fiscal year | R&D expense | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $225M | +7.1% | Open → |
| FY20242024-12-31 | $210M | −6.0% | Open → |
| FY20232023-12-31 | $223M | +8.2% | Open → |
| FY20222022-12-31 | $206M | +2.4% | Open → |
| FY20212021-12-31 | $201M | +52.5% | Open → |
| FY20202020-12-31 | $132M | +67.1% | Open → |
| FY20192019-12-31 | $79.0M | +56.2% | Open → |
| FY20182018-12-31 | $50.6M | +32.7% | Open → |
| FY20172017-12-31 | $38.1M | −8.1% | Open → |
| FY20162016-12-31 | $41.5M | −5.2% | Open → |
| FY20152015-12-31 | $43.7M | +8.3% | Open → |
| FY20142014-12-31 | $40.4M | +16.0% | Open → |
| FY20132013-12-31 | $34.8M | — | Open → |
R&D expense — Research and development expense is what the company charged to R&D in the income statement for the year. Most companies report no R&D at all — the line is absent rather than zero — so this ranking covers the roughly 40% of filers that do.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2013–2025 compound annual growth +16.8%
R&D expense at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Novocure R&D expense |url=https://companiesranked.com/en/company/novocure/research-and-development-expense |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Novocure R&D expense. CompaniesRanked. https://companiesranked.com/en/company/novocure/research-and-development-expenseBibTeX
@misc{companiesranked-en-company-novocure-research-and-development-expense-2026,
author = {{CompaniesRanked}},
title = {{Novocure R\&D expense}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/novocure/research-and-development-expense}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-Q · 0001645113-26-000062 · July 23, 2026
{{cite web |title=Novocure R&D expense — 10-Q (0001645113-26-000062) |url=https://www.sec.gov/Archives/edgar/data/1645113/000164511326000062/nvcr-20260630.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-07-23}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.